Annual EBITDA
-$4.86 M
-$1.45 M-42.32%
31 December 2023
Summary:
Protagenic Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$4.86 million, with the most recent change of -$1.45 million (-42.32%) on 31 December 2023. During the last 3 years, it has fallen by -$2.56 million (-111.29%). PTIX annual EBITDA is now -230.59% below its all-time high of $3.73 million, reached on 31 July 2000.PTIX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$628.20 K
+$965.80 K+60.59%
30 September 2024
Summary:
Protagenic Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$628.20 thousand, with the most recent change of +$965.80 thousand (+60.59%) on 30 September 2024. Over the past year, it has increased by +$735.10 thousand (+53.92%). PTIX quarterly EBITDA is now -116.40% below its all-time high of $3.83 million, reached on 31 July 2000.PTIX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$5.57 M
+$735.10 K+11.66%
30 September 2024
Summary:
Protagenic Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$5.57 million, with the most recent change of +$735.10 thousand (+11.66%) on 30 September 2024. Over the past year, it has dropped by -$1.77 million (-46.70%). PTIX TTM EBITDA is now -183.44% below its all-time high of $6.68 million, reached on 31 July 2000.PTIX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTIX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.3% | +53.9% | -46.7% |
| 3 y3 years | -111.3% | +17.8% | -53.7% |
| 5 y5 years | -90.2% | -409.9% | -215.0% |
PTIX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -111.3% | at low | -10.3% | +63.3% | -100.6% | +11.7% |
| 5 y | 5 years | -180.4% | at low | -409.9% | +63.3% | -249.3% | +11.7% |
| alltime | all time | -230.6% | +95.6% | -116.4% | +99.5% | -183.4% | +95.4% |
Protagenic Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$628.20 K(-60.6%) | -$5.57 M(-11.7%) |
| June 2024 | - | -$1.59 M(-6.9%) | -$6.31 M(+7.1%) |
| Mar 2024 | - | -$1.71 M(+4.6%) | -$5.89 M(+21.1%) |
| Dec 2023 | -$4.86 M(+42.3%) | -$1.64 M(+20.1%) | -$4.86 M(+28.1%) |
| Sept 2023 | - | -$1.36 M(+15.7%) | -$3.80 M(+14.1%) |
| June 2023 | - | -$1.18 M(+71.5%) | -$3.33 M(+19.8%) |
| Mar 2023 | - | -$686.70 K(+20.6%) | -$2.78 M(-18.8%) |
| Dec 2022 | -$3.42 M(-15.1%) | -$569.40 K(-36.3%) | -$3.42 M(-7.1%) |
| Sept 2022 | - | -$893.30 K(+42.5%) | -$3.68 M(+3.6%) |
| June 2022 | - | -$627.00 K(-52.8%) | -$3.55 M(-16.1%) |
| Mar 2022 | - | -$1.33 M(+59.8%) | -$4.23 M(+5.1%) |
| Dec 2021 | -$4.03 M(+74.9%) | -$831.10 K(+8.8%) | -$4.03 M(+11.1%) |
| Sept 2021 | - | -$763.80 K(-41.6%) | -$3.63 M(-5.8%) |
| June 2021 | - | -$1.31 M(+16.6%) | -$3.85 M(+26.1%) |
| Mar 2021 | - | -$1.12 M(+160.9%) | -$3.05 M(+27.7%) |
| Dec 2020 | -$2.30 M(+32.7%) | -$430.20 K(-56.4%) | -$2.39 M(-11.3%) |
| Sept 2020 | - | -$987.20 K(+92.7%) | -$2.69 M(+47.2%) |
| June 2020 | - | -$512.30 K(+11.5%) | -$1.83 M(+14.7%) |
| Mar 2020 | - | -$459.50 K(-37.4%) | -$1.59 M(-8.0%) |
| Dec 2019 | -$1.73 M(-32.2%) | -$733.90 K(+495.7%) | -$1.73 M(-1.9%) |
| Sept 2019 | - | -$123.20 K(-55.7%) | -$1.77 M(-17.5%) |
| June 2019 | - | -$278.40 K(-53.5%) | -$2.14 M(-15.9%) |
| Mar 2019 | - | -$599.10 K(-22.0%) | -$2.55 M(-0.3%) |
| Dec 2018 | -$2.56 M(+8.1%) | -$767.60 K(+54.1%) | -$2.56 M(+2.4%) |
| Sept 2018 | - | -$498.00 K(-27.3%) | -$2.50 M(-1.1%) |
| June 2018 | - | -$685.00 K(+12.9%) | -$2.53 M(+9.2%) |
| Mar 2018 | - | -$606.60 K(-14.4%) | -$2.31 M(-2.1%) |
| Dec 2017 | -$2.37 M(+4.3%) | -$708.70 K(+34.5%) | -$2.36 M(+6.9%) |
| Sept 2017 | - | -$526.90 K(+11.7%) | -$2.21 M(+3.3%) |
| June 2017 | - | -$471.60 K(-28.2%) | -$2.14 M(-2.3%) |
| Mar 2017 | - | -$657.00 K(+18.2%) | -$2.19 M(-3.4%) |
| Dec 2016 | -$2.27 M(+370.6%) | -$555.90 K(+22.1%) | -$2.27 M(+21.7%) |
| Sept 2016 | - | -$455.30 K(-12.9%) | -$1.86 M(+21.2%) |
| June 2016 | - | -$522.60 K(-28.8%) | -$1.54 M(+36.6%) |
| Mar 2016 | - | -$734.30 K(+386.3%) | -$1.13 M(+120.2%) |
| Dec 2015 | - | -$151.00 K(+17.1%) | -$511.00 K(+3.2%) |
| Sept 2015 | - | -$129.00 K(+16.2%) | -$495.00 K(+2.7%) |
| June 2015 | -$482.00 K(-47.7%) | -$111.00 K(-7.5%) | -$482.00 K(+0.6%) |
| Mar 2015 | - | -$120.00 K(-11.1%) | -$479.00 K(-35.2%) |
| Dec 2014 | - | -$135.00 K(+16.4%) | -$739.00 K(-11.6%) |
| Sept 2014 | - | -$116.00 K(+7.4%) | -$836.00 K(-9.3%) |
| June 2014 | -$921.00 K(+14.3%) | -$108.00 K(-71.6%) | -$922.00 K(+13.3%) |
| Mar 2014 | - | -$380.00 K(+63.8%) | -$814.00 K(+87.6%) |
| Dec 2013 | - | -$232.00 K(+14.9%) | -$434.00 K(+114.9%) |
| Sept 2013 | - | -$202.00 K(-95.2%) | -$202.00 K(-99.0%) |
| June 2013 | -$806.00 K(-95.7%) | - | - |
| Sept 2011 | - | -$4.24 M(-12.4%) | -$20.96 M(+4.9%) |
| June 2011 | - | -$4.83 M(+48.7%) | -$19.99 M(+3.8%) |
| Mar 2011 | - | -$3.25 M(-62.4%) | -$19.27 M(+1.7%) |
| Dec 2010 | -$18.95 M | -$8.64 M(+165.0%) | -$18.95 M(-34.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | -$3.26 M(-20.6%) | -$28.87 M(-4.1%) |
| June 2010 | - | -$4.11 M(+39.9%) | -$30.12 M(+8.2%) |
| Mar 2010 | - | -$2.94 M(-84.2%) | -$27.84 M(+11.0%) |
| Dec 2009 | -$25.09 M(-77.3%) | -$18.56 M(+311.4%) | -$25.09 M(-79.2%) |
| Sept 2009 | - | -$4.51 M(+146.2%) | -$120.65 M(+5.3%) |
| June 2009 | - | -$1.83 M(+890.3%) | -$114.57 M(+3.9%) |
| Mar 2009 | - | -$185.00 K(-99.8%) | -$110.28 M(+0.3%) |
| Dec 2008 | -$110.63 M(+2565.7%) | -$114.13 M(-7359.9%) | -$109.91 M(-3253.8%) |
| Sept 2008 | - | $1.57 M(-36.2%) | $3.48 M(+1575.5%) |
| June 2008 | - | $2.46 M(+1268.3%) | $208.00 K(-105.3%) |
| Mar 2008 | - | $180.00 K(-124.7%) | -$3.89 M(-6.2%) |
| Dec 2007 | -$4.15 M(-376.9%) | -$730.00 K(-57.2%) | -$4.15 M(+21.3%) |
| Sept 2007 | - | -$1.71 M(+4.1%) | -$3.42 M(+97.8%) |
| June 2007 | - | -$1.64 M(+2027.3%) | -$1.73 M(-28.9%) |
| Mar 2007 | - | -$77.00 K(+434.7%) | -$2.43 M(+8.8%) |
| Dec 2006 | $1.50 M(-2211.3%) | - | - |
| Oct 2006 | - | -$14.40 K(-99.4%) | -$2.23 M(-1.6%) |
| July 2006 | - | -$2.34 M(-1900.0%) | -$2.27 M(-3347.6%) |
| July 2006 | -$71.00 K(-24.9%) | - | - |
| Apr 2006 | - | $130.00 K(-1440.2%) | $69.90 K(-216.3%) |
| Jan 2006 | - | -$9700.00(-80.8%) | -$60.10 K(+19.2%) |
| Oct 2005 | - | -$50.40 K(-119.6%) | -$50.40 K(-112.4%) |
| July 2005 | -$94.50 K(<-9900.0%) | - | - |
| July 2004 | $0.00(-100.0%) | - | - |
| Apr 2003 | - | $257.00 K(+729.0%) | $407.00 K(-30.9%) |
| Jan 2003 | - | $31.00 K(-78.0%) | $589.00 K(-34.3%) |
| Oct 2002 | - | $141.00 K(-740.9%) | $897.00 K(-42.7%) |
| July 2002 | $1.57 M(-43.5%) | -$22.00 K(-105.0%) | $1.57 M(-13.0%) |
| Apr 2002 | - | $439.00 K(+29.5%) | $1.80 M(-10.4%) |
| Jan 2002 | - | $339.00 K(-58.1%) | $2.01 M(-19.7%) |
| Oct 2001 | - | $810.00 K(+282.1%) | $2.50 M(-9.8%) |
| July 2001 | $2.77 M(-25.5%) | $212.00 K(-67.3%) | $2.77 M(-56.6%) |
| Apr 2001 | - | $649.00 K(-22.0%) | $6.39 M(-2.4%) |
| Jan 2001 | - | $832.00 K(-23.0%) | $6.55 M(-1.0%) |
| Oct 2000 | - | $1.08 M(-71.8%) | $6.62 M(-0.8%) |
| July 2000 | $3.73 M(+127.6%) | $3.83 M(+373.5%) | $6.68 M(+22.0%) |
| Apr 2000 | - | $809.00 K(-10.1%) | $5.47 M(+8.4%) |
| Jan 2000 | - | $900.00 K(-20.8%) | $5.05 M(+4.1%) |
| Oct 1999 | - | $1.14 M(-56.7%) | $4.85 M(+7.4%) |
| July 1999 | $1.64 M(-32.2%) | $2.63 M(+580.1%) | $4.51 M(-6.0%) |
| Apr 1999 | - | $386.00 K(-44.9%) | $4.80 M(-9.7%) |
| Jan 1999 | - | $700.00 K(-12.5%) | $5.31 M(+6.0%) |
| Oct 1998 | - | $800.00 K(-72.5%) | $5.01 M(+4.2%) |
| July 1998 | $2.41 M(+382.8%) | $2.91 M(+223.8%) | $4.81 M(+140.7%) |
| Apr 1998 | - | $900.00 K(+125.0%) | $2.00 M(+33.3%) |
| Jan 1998 | - | $400.00 K(-33.3%) | $1.50 M(+66.7%) |
| Oct 1997 | - | $600.00 K(+500.0%) | $900.00 K(-75.0%) |
| July 1997 | $500.00 K | $100.00 K(-75.0%) | $3.60 M(+2.9%) |
| Apr 1997 | - | $400.00 K(-300.0%) | $3.50 M(+12.9%) |
| Jan 1997 | - | -$200.00 K(-106.1%) | $3.10 M(-6.1%) |
| Oct 1996 | - | $3.30 M | $3.30 M |
FAQ
- What is Protagenic Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual EBITDA year-on-year change?
- What is Protagenic Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly EBITDA year-on-year change?
- What is Protagenic Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Protagenic Therapeutics?
- What is Protagenic Therapeutics TTM EBITDA year-on-year change?
What is Protagenic Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PTIX is -$4.86 M
What is the all time high annual EBITDA for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is $3.73 M
What is Protagenic Therapeutics annual EBITDA year-on-year change?
Over the past year, PTIX annual earnings before interest, taxes, depreciation & amortization has changed by -$1.45 M (-42.32%)
What is Protagenic Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PTIX is -$628.20 K
What is the all time high quarterly EBITDA for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is $3.83 M
What is Protagenic Therapeutics quarterly EBITDA year-on-year change?
Over the past year, PTIX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$735.10 K (+53.92%)
What is Protagenic Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PTIX is -$5.57 M
What is the all time high TTM EBITDA for Protagenic Therapeutics?
Protagenic Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is $6.68 M
What is Protagenic Therapeutics TTM EBITDA year-on-year change?
Over the past year, PTIX TTM earnings before interest, taxes, depreciation & amortization has changed by -$1.77 M (-46.70%)